Form4insider filings, from the source

SEC Form 4 · accession 0001363763-15-000010

RespireRx Pharmaceuticals Inc. · RSPI

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner
Jeff Eliot Margolis
Officer — VP, Treasurer & Secretary · Director
Period of report
Aug 18, 2015
Accepted (ET)
Aug 20, 2015 · 5:03 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000849636

Table I — non-derivative securities

No Table I lines on this filing.

Table II — derivative securities

SecurityConv. / exercise priceDateCodeSharesA/DExercisableExpiresUnderlyingUnderlying sharesOwned afterD/I
Common Stock Options (to purchase shares of Common Stock)F2,F1$0.0197Aug 18, 2015A10,000,000A—Aug 18, 2022Common Stock10,000,00010,000,000D
Warrants (right to buy)F2,F3$0.035holding————Sep 15, 2015Common Stock507,374507,374D
Common Stock Options (to purchase shares of Common Stock)F2,F4$0.025holding————Jun 30, 2022Common Stock15,000,00015,000,000D
Common Stock Options (to purchase shares of Common Stock)F6,F5$0.05holding————Jul 17, 2019Common Stock5,000,0005,000,000D

Explanation of responses